Erythropoietin-inducible immediate-early genes in human vascular endothelial cells

Journal of Investigative Medicine

Volumn 48, Issue 2, 2000, Pages 137-149

  Fodinger, M ^a   Fritsche Polanz, R ^a   Buchmayer, H ^a   Skoupy, S ^a   Sengoelge, G ^a   Horl, W H ^a   Sunder Plassmann, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Differential display; Endothelial cells; Gene expression; Immediate early genes; Recombinant human erythropoietin

Indexed keywords

ERYTHROPOIETIN RECEPTOR; GENE PRODUCT; MESSENGER RNA; MYOSIN LIGHT CHAIN; PROTEIN TYROSINE PHOSPHATASE; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOSOME PROTEIN; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR; TRYPTOPHAN TRANSFER RNA LIGASE;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENERGY TRANSFER; ENZYME SUBUNIT; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; NUCLEOTIDE SEQUENCE; RNA TRANSLATION; SEQUENCE ANALYSIS; SIDE EFFECT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0033771732     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Erythropoietin
2. Cloning and expression of the human erythropoietin gene
3. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
4. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial
5. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial
6. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile
7. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients
8. Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?
9. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis
10. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells
11. Erythropoietin receptor. Subunit structure and activation
12. Homodimerization and constitutive activation of the erythropoietin receptor
13. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
14. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis
15. Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line
16. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells
17. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity
18. Signal transduction through the receptor for erythropoietin
19. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells
20. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-γ1 in a human erythropoietin-dependent cell line
21. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor
22. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
23. Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells
24. Recombinant human erythropoietin stimulates angiogenesis in vitro
25. rHuEPO enhances the production of plasminogen activator inhibitor-1 in cultured endothelial cells
26. Signal transduction of erythropoietin in endothelial cells
27. Immediate-early genes: Ten years on
28. Immediate-early genes induced by antigen receptor stimulation
29. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
30. Isolation of interleukin 2-induced immediate-early genes
31. Functional characterization of cytokine autoantibodies in chronic renal failure patients
32. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
33. Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation
34. Basic local alignment search tool
35. Improved tools for biological sequence comparison
36. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells
37. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release
38. Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera
39. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin
40. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins
41. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis
42. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression
43. Human nonsarcomeric 20,000 Da myosin regulatory light chain cDNA
44. Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins
45. Human interferon γ potently induces the synthesis of a 55-kDa protein (γ2) highly homologous to rabbit peptide chain release factor and bovine tryptophanyl-tRNA synthetase
46. Cloning and characterization of a human cDNA encoding a novel putative cytoplasmic protein-tyrosinephosphatase
47. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation
48. Recent African origin of modern humans revealed by complete sequences of hominoid mitochondrial DNAs
49. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene
50. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin
51. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
52. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts
53. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription
54. A thrombin-sensitive protein of human platelet membranes
55. The structural and functional properties of thrombospondin
56. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor
57. Thrombospondins
58. Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells
59. Light microscopic immunolocation of thrombospondin in human tissues
60. Immunocytochemical features of obstructed saphenous vein coronary artery bypass grafts
61. Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains
62. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries
63. A monoclonal antibody against human thrombospondin inhibits platelet aggregation
64. Characterization of the antiplasmin activity of human thrombospondin-1 in solution
65. Increased adhesion of erythrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin
66. Purification and characterization of smooth muscle myosin light chain kinase
67. Regulation of contractile proteins by phosphorylation
68. Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation
69. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells
70. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells
71. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids
72. Recombinant human erythropoietin does not regulate the expression of endothelin-1 and constitutive nitric oxide synthase in vascular endothelial cells
73. A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor
74. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers
75. Biphasic regulation of the preproendothelin-1 gene by c-myc
76. Probing the assembly of the 3' major domain of 16 S ribosomal RNA. Quaternary interactions involving ribosomal proteins S7, S9 and S19
77. The effect of serum, EGF, PGF(2α) and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis
78. Transcriptional and translational regulation of ribosomal protein formation during mouse myeloblast differentiation
79. Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts
80. A mammalian tryptophanyl-tRNA synthetase is associated with protein kinase activity
81. The respiratory-chain NADH dehydrogenase (complex I) of mitochondria
82. On the function of multiple subunits of cytochrome C oxidase from higher eukaryotes
83. Crosstalk between nuclear and mitochondrial genomes
84. Cloning and expression of PTP-PEST. A novel, human, nontransmembrane protein tyrosine phosphatase
85. Inhibitory tyrosine protein kinase p50(csk) is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells
86. Activators of protein kinase C stimulate association of Shc and the PEST tyrosine phosphatase
87. Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin
88. PTP-PEST: A protein tyrosine phosphatase regulated by serine phosphorylation
89. Mono-ADP-ribosylation: A reversible post-translational modification of proteins
90. Cell surface ADP-ribosyltransferase regulates lymphocyte function-associated molecule-1 (LFA-1) function in T cells
91. Regulation of CTL by ectonicotinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56(lck)-associated protein
92. Integrin α7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells
93. Molecular cloning of gene sequences regulated by platelet-derived growth factor
94. In search of cytokine-response genes
95. Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis
96. Vascular endothelial cadherin (VE-cadherin): Cloning and role in endothelial cell-cell adhesion